TIREOTOKSIKOZ FONIDA KO‘Z OLMASINING KLINIK MORFOLOGIK XUSUSIYATLARI (ADABIYOTLAR TAHLILI)
DOI:
https://doi.org/10.57231/j.ao.2024.7.1.003Ключевые слова:
endokrin oftalmopatiya (EOP), distireoid optik neyropatiya (DON), periorbital to‘qimalar, ekstraokulyar mushaklar, tireotoksik ekzoftalm, tireoid assotsirlangan orbitopatiya (TAO), ultratovush tekshiruvi, OKT-optik kogerent tomografiyaАннотация
Dolzarbligi. Butun jahon so‘g‘liqni saqlash tashkiloti (BJSST) statistik ma’lumotlariga ko‘ra dunyo aholisi orasida endokrin patologiya hisoblangan qalqonsimon bez kasalliklari tarqalishi jihatidan qandli diabetdan keyingi ikkinchi o‘rinda turadi. Tireotoksikoz butun dunyo bo‘ylab voyaga yetgan aholining 2,5 foizida, shuningdek ayollar o‘rtasida tireotoksikoz kasalligi erkaklarga nisbatan 10 baravar ko‘p kuzatiladi. Tadqiqot maqsadi. Keyingi 10–15 yil mobaynida tireotoksikoz kasalligida ko’rish a’zolarida kuzatiladigan o’zgarishlar to’g’risidagi ma’lumotlarni o’z ichiga olgan ilmiy adabiyotlar tahlilini o’tkazish. Material va usullar. Respublikamizda va chet ellardagi nufuzli nashrlarda chop etilgan ilmiy maqolalar hamda ilmiy axborot resurs manbalaridan foydalanilgan holda ularni o’rganish. Natijalar va xulosa. Endokrin oftalmopatiya tashxisli bemorlarda UTT, KT va MRT diagnostik tekshiruvlari ko‘z olmasi va orbita yumshoq to‘qimalarining morfologik xususiyatlarini o‘rgnish va mazkur patologiyani erta bosqichlarda aniqlash imkonini beradi. Tekshiruv turlari ichida UTT inson tanasiga salbiy ta’sirlarining yo‘qligi va informativ metod sifatida klinik amaliyotda keng foydalanishga tavsiya etilishi mumkin.
Библиографические ссылки
Bartley G.B. (1994). The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Transactions of the American Ophthalmological Society, 92, 477–588
Pavlova T.L., Kotova G. A., Gerasimov G. A. Endocrine ophthalmopathy. Problems of Endocrinology. 1998;44(2):22–27. (In Russ.) https://doi.org/10.14341/probl199844222–27
Wang, Y., & Smith, T.J. (2014). Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Investigative ophthalmology & visual science, 55(3), 1735–1748. https://doi.org/10.1167/iovs.14–14002
Boschi, A., Daumerie, C.h, Spiritus, M., Beguin, C., Senou, M., Yuksel, D., Duplicy, M., Costagliola, S., Ludgate, M., & Many, M. C. (2005). Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy. The British journal of ophthalmology, 89(6), 724–729. https://doi.org/10.1136/bjo.2004.050807
Eckstein, A.K., Plicht, M., Lax, H., Neuhäuser, M., Mann, K., Lederbogen, S., Heckmann, C., Esser, J., & Morgenthaler, N. G. (2006). Thyrotropin receptor autoantibodies are independent risk factors for Graves’ ophthalmopathy and help to predict severity and outcome of the disease. The Journal of clinical endocrinology and metabolism, 91(9), 3464–3470. https://doi.org/10.1210/jc.2005–2813
Khoo, T.K., & Bahn, R.S. (2007). Pathogenesis of Graves’ ophthalmopathy: The role of autoantibodies. Thyroid (New York, N.Y.), 17(10), 1013–1018. https://doi.org/10.1089/thy.2007.0185 7. Chng, C.L., Lai, O.F., Chew, C.S., Peh, Y.P., Fook-Chong, S.M., Seah, L.L., & Khoo, D.H. (2014). Hypoxia increases adipogenesis and affects adipocytokine production in orbital fibroblasts-a possible explanation of the link between smoking and Graves’ ophthalmopathy. International journal of ophthalmology, 7(3), 403–407. https://doi.org/10.3980/j.issn.2222–3959.2014.03.03
Wynn, T.A., & Ramalingam, T.R. (2012). Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nature medicine, 18(7), 1028–040. https://doi.org/10.1038/nm.2807
Barrett, L., Glatt, H.J., Burde, R.M., & Gado, M.H. (1988). Optic nerve dysfunction in thyroid eye disease: CT. Radiology,167(2), 503–507. https://doi.org/10.1148/radiology.167.2.3357962
Anderson, R.L., Tweeten, J.P., Patrinely, J.R., Garland, P.E., & Thiese, S.M. (1989). Dysthyroid optic neuropathy without extraocular muscle involvement. Ophthalmic surgery, 20(8), 568–574.
Weber, A.L., Dallow, R. L., & Sabates, N.R. (1996). Graves’ disease of the orbit. Neuroimaging clinics of North America, 6(1), 61–72.
Fang, Z.J., Zhang, J.Y., & He, W.M. (2013). CT features of exophthalmos in Chinese subjects with thyroid-associated ophthalmopathy. International journal of ophthalmology, 6(2), 146–149. https://doi.org/10.3980/j.issn.2222–3959.2013.02.07
Trokel, S., Kazim, M., & Moore, S. (1993). Orbital fat removal. Decompression for Graves orbitopathy. Ophthalmology, 100(5), 674–682. https://doi.org/10.1016/s0161–6420(93)31589–7
Gonçalves, A.C., Silva, L.N., Gebrim, E.M., & Monteiro, M.L. (2012). Quantification of orbital apex crowding for screening of dysthyroid optic neuropathy using multidetector CT. AJNR. American journal of neuroradiology, 33(8), 1602–1607. https://doi.org/10.3174/ajnr.A3029
McKeag, D., Lane, C., Lazarus, J. H., Baldeschi, L., Boboridis, K., Dickinson, A. J., Hullo, A. I., Kahaly, G., Krassas, G., Marcocci, C., Marinò, M., Mourits, M. P., Nardi, M., Neoh, C., Orgiazzi, J., Perros, P., Pinchera, A., Pitz, S., Prummel, M. F., Sartini, M. S., European Group on Graves’ Orbitopathy (EUGOGO) (2007). Clinical features of dysthyroid optic neuropathy: a European Group on Graves’ Orbitopathy (EUGOGO) survey. The British journal of ophthalmology, 91(4), 455–458. https://doi.org/10.1136/bjo.2006.094607
Chan, L.L., Tan, H.E., Fook-Chong, S., Teo, T.H., Lim, L.H., & Seah, L.L. (2009). Graves ophthalmopathy: the bony orbit in optic neuropathy, its apical angular capacity, and impact on prediction of risk. AJNR. American journal of neuroradiology, 30(3), 597–602. https://doi.org/10.3174/jnr.A1413
Bahn R.S. (2015). Current Insights into the Pathogenesis of Graves’ Ophthalmopathy. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 47(10), 773–778. https://doi.org/10.1055/s‑0035–1555762
Barrio-Barrio, J., Sabater, A.L., Bonet-Farriol, E., Velázquez-Villoria, Á., & Galofré, J.C. (2015). Graves’ Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management. Journal of ophthalmology, 2015, 249125. https://doi.org/10.1155/2015/249125
Dolman P.J. (2012). Evaluating Graves’ orbitopathy. Best practice & research. Clinical endocrinology & metabolism, 26(3), 229–248. https://doi.org/10.1016/j.beem.2011.11.007
El-Kaissi, S., Frauman, A.G., & Wall, J.R. (2004). Thyroid-associated ophthalmopathy: a practical guide to classification, natural history and management. Internal medicine journal, 34(8), 482–491. https://doi.org/10.1111/j.1445–5994.2004.00662.x 21. Şahlı, E., & Gündüz, K. (2017). Thyroid-associated Ophthalmopathy. Turkish journal of ophthalmology, 47(2), 94–105. https://doi.org/10.4274/tjo.80688
Marique, L., Sènou, M., Craps, J., Delaigle, A., Van Regemorter, E., Wérion, A., Van Regemorter, V., Mourad, M., Behets, C., Lengelé, B., Baldeschi, L., Boschi, A., Brichard, S., Daumerie, C., & Many, M. (2015b). Oxidative Stress and Upregulation of Antioxidant Proteins, Including Adiponectin, in Extraocular Muscular Cells, Orbital Adipocytes, and Thyrocytes in Graves’ Disease Associated with Orbitopathy. Thyroid (New York, N.Y.), 25(9), 1033–1042. https://doi.org/10.1089/thy.2015.0087
Karhanová, M., Kalitová, J., Kovář, R., Schovánek, J., Karásek, D., Čivrný, J., Hübnerová, P., Mlčák, P., & Šín, M. (2022). Ocular hypertension in patients with active thyroid-associated orbitopathy: a predictor of disease severity, particularly of extraocular muscle enlargement Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 260(12),
–3984. https://doi.org/10.1007/s00417–022–05760–0
Ponto, K.A., Pitz, S., Pfeiffer, N., Hommel, G., Weber, M.M., & Kahaly, G.J. (2009). Quality of life and occupational disability in endocrine orbitopathy. Deutsches Ärzteblatt International. https://doi.org/10.3238/arztebl.2009.0283
Verma, R., Chen, A.J., Choi, D., Wilson, D.J., Grossniklaus, H.E., Dailey, R.A., Ng, J.D., Steele, E.A., Planck, S.R., Czyz, C.N., Korn, B.S., Kikkawa, D.O., Foster, J.A., Kazim, M., Harris, G.J., Edward, D.P., Al Maktabi, A., & Rosenbaum, J.T. (2023). Inflammation and Fibrosis in Orbital Inflammatory Disease: A Histopathologic Analysis. Ophthalmic plastic and reconstructive surgery, 39(6), 588–593. https://doi.org/10.1097/IOP.0000000000002410
Тетенькина А.Н., Лекомцева Н. П. Эхографические исследования в диагностике эндокринной офтальмопатии // Международный студенческий научный вестник. — 2015. — № 2–1; Эхографические исследования в диагностике эндокринной офтальмопатии — Студенческий научный форум. (n. d.). https://scienceforum.ru/2015/article/2015017474
Nozimov E. Akhmadjon, Bilalov N. Erkin, Akhmedova M. Sayyora, Yuldashov A.Sarvarkhon. Ultrasound examination of extraocular muscles in patients diagnosed with endocrineophthalmopathy // Journal of biomedicine and practice. 2024, vol. 9, issue 1, pp 272–279. http://dx.doi.org/10.5281/zenodo.10895988
Karhanová, M., Kovář, R., Fryšák, Z., Zapletalová, J., Marešová, K. B., Sin, M. L. M., & Moreno, H. (2014). [Extraocular muscle involvement in patients with thyroid-associated orbitopathy]. PubMed, 70(2), 66–71. https://pubmed.ncbi.nlm.nih.gov/25030316
Karhanová, M., Kovář, R., Fryšák, Z., Šín, M., Zapletalová, J., Řehák, J., & Moreno, H. (2015b). Correlation between magnetic resonance imaging and ultrasound measurements of eye muscle thickness in thyroid-associated orbitopathy. Biomedical Papers/Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc Czech Republic, 159(2), 307–312. https://doi.org/10.5507/bp.2014.001
Park, K., Kim, Y., Woo, K. I., Kee, C., & Han, J. C. (2016). Optical coherence tomography measurements in compressive optic neuropathy associated with dysthyroid orbitopathy. Graefe’s Archive for Clinical and Experimental Ophthalmology, 254(8), 1617–1624. https://doi.org/10.1007/s00417–016–3335–9
Maruko, I., Iida, T., Sugano, Y., Ojima, A., Ogasawara, M., & Spaide, R. F. (2010). Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology,117(9),1792–1799. https://doi.org/10.1016/j.ophtha.2010.01.023
Khanifar, A.A., Parlitsis, G.J., Ehrlich, J.R., Aaker, G.D., D’Amico, D.J., Gauthier, S.A., & Kiss, S. (2010). Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography. Clinical ophthalmology (Auckland, N.Z.), 4, 1007–1013. https://doi.org/10.2147/opth.s13278
Burch, H.B., Perros, P., Bednarczuk, T., Cooper, D.S., Dolman, P.J., Leung, A. M., Mombaerts, I., Salvi, M., & Stan, M.N. (2022). Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association. European thyroid journal, 11(6), e220189. https://doi.org/10.1530/ETJ‑22–0189
Нугманова Л.Б., Абдазова Р. Б. Влияние хирургического лечения диффузного токсического зоба на динамику эндокринной офтальмопатии//сборник трудов Республиканской научно-практической конференции Актуальные проблемы патологии щитовидной железы.-Ташкент, 2006.190–191.
Romano, M.R., Cennamo, G., Breve, M.A., Piedepalumbo, M., Iovino, C., Velotti, N., & Cennamo, G. (2017). Optic nerve compression: the role of the lamina cribrosa and translaminar pressure. International journal of ophthalmology, 10(12), 1883–1888. https://doi.org/10.18240/ijo.2017.12.15
Yu, L., Jiao, Q., Cheng, Y., Zhu, Y., Lin, Z., & Shen, X. (2020). Evaluation of retinal and choroidal variations in thyroid-associated ophthalmopathy using optical coherence tomography angiography. BMC ophthalmology, 20(1), 421. https://doi.org/10.1186/s12886–020–01692–7
Rajabi, M.T., Ojani, M., Riazi Esfahani, H., Tabatabaei, S. Z., Rajabi, M. B., & Hosseini, S. S. (2018). Correlation of peripapillary nerve fiber layer thickness with visual outcomes after decompression surgery in subclinical and clinical thyroid-related compressive optic neuropathy. Journal of current ophthalmology, 31(1), 86–91. https://doi.org/10.1016/j.joco.2018.11.003
Çalışkan, S., Acar, M., & Gürdal, C. (2017). Choroidal Thickness in Patients with Graves’ Ophthalmopathy. Current eye research, 42(3), 484–490. https://doi.org/10.1080/02713683.2016.1198488
Sezer, T., Altınışık, M., Koytak, İ. A., & Özdemir, M. H. (2016). The choroid and Optical coherence tomography. TüRk Oftalmoloji Dergisi, 46(1), 30–37. https://doi.org/10.4274/tjo.10693
Laviers, H., & Zambarakji, H. (2014). Enhanced depth imaging-OCT of the choroid: a review of the current literature. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 252(12), 1871–1883. https://doi.org/10.1007/s00417–014–2840‑y
Agrawal, R., Gupta, P., Tan, K. A., Cheung, C. M., Wong, T. Y., & Cheng, C. Y. (2016). Choroidal vascularity index as a measure of vascular status of the choroid: Measurements in healthy eyes from a population-based study. Scientific reports, 6, 21090. https://doi.org/10.1038/srep21090
Sonoda, S., Sakamoto, T., Yamashita, T., Uchino, E., Kawano, H., Yoshihara, N., Terasaki, H., Shirasawa, M., Tomita, M., & Ishibashi, T. (2015). Luminal and stromal areas of choroid determined by binarization method of optical coherence tomographic images American journal of ophthalmology, 159(6), 1123–1131.e1. https://doi.org/10.1016/j.ajo.2015.03.005
Kurt, M.M., Akpolat, C., Evliyaoglu, F., Yilmaz, M., & Ordulu, F. (2021). Evaluation of Retinal Neurodegeneration and Choroidal Thickness in Patients with Inactive Graves’ Ophthalmopathy. Beurteilung der retinalen Neurodegeneration und der Dicke der Aderhaut bei Patienten mit inaktiver Graves-Ophthalmopathie. Klinische Monatsblatter fur Augenheilkunde, 238(7), 797–802. https://doi.org/10.1055/a‑1275–0703
Häner, N.U., Dysli, M., Abegg, M., & Zinkernagel, M.S. (2015). Enhanced-depth optical coherence tomography for imaging horizontal rectus muscles in Graves’ orbitopathy. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 253(9), 1569–1573. https://doi.org/10.1007/s00417–015–3060–9
Янгиева, Н., Туйчибаева, Д., & Абасханова, Н. (2014). Применение «цитиколина» в комплексном лечении больных возрастной макулпрной дегенерацией. in Library, 1(1), 33–38. извлечено от https://inlibrary.uz/index.php/archive/article/view/14476
Янгиева, Н. Р., Туйчибаева, Д. М., Абасханова, Н. Х. Возможности ноотропной терапии в комплексном лечении больных первичной открытоугольной глаукомой. Национальный журнал глаукома. 2014;2:70-77. https://www.glaucomajournal.ru/jour/article/view/18/19
Tuychibaeva D. Epidemiological and clinical-functional aspects of the combined course of age-related macular degeneration and primary glaucoma. J.ophthalmol. (Ukraine). 2023;3:3-8. https://doi.org/10.31288/oftalmolzh2023338
Туйчибаева Д.М.. Ким А.А. Современные аспекты лечения кератоконуса. Обзор. Офтальмология. Восточная Европа. 2023;1(13):73-89. [Tuychibaeva D.M., Kim A.А. Modern Aspects of Keratoconus Treatment. A Review. Ophthalmology. Eastern Europe, 2023;13.1:73-89. (in Russ)]. https://doi.org/10.34883/PI.2023.13.1.019
Туйчибаева Д.М. Основные характеристики динамики показателей инвалидности вследствие глаукомы в Узбекистане. Офтальмология. Восточная Европа. 2022;12.2:195-204. [Tuychibaeva D.M. Main Characteristics of the Dynamics of Disability Due to Glaucoma in Uzbekistan. "Ophthalmology. Eastern Europe", 2022;12.2:195-204. (in Russian)]. https://doi.org/10.34883/PI.2022.12.2.027
Tuychibaeva DM. Longitudinal changes in the disability due to glaucoma in Uzbekistan. J.ophthalmol. (Ukraine). 2022;4:12-17. http://doi.org/10.31288/oftalmolzh202241217
Янгиева, Н.Р., Туйчибаева Д.М. Клиническая оценка эффективности комплексного лечения возрастной макулодистрофии // Современные технологии в офтальмологии. – 2017. – № 3. – С. 276-280. – EDN ZENRBT.
Янгиева Н.Р, Туйчибаева Д.М. Эффективность вторичной профилактики возрастной макулярной дегенерации. Биология ва тиббиёт муаммолари. 2021; 21(3):158–161. [Yangieva NR, Tuychibaeva DM. The effectiveness of secondary prevention of age-related macular degeneration. Biology va tibbiyot muammolari. 2021; 21(3):158–161. (In Russ.)].
Agzamova S.S. Improvement of diagnostics and treatment of ophthalmic complications in zygomatic and orbital injuries. "Ophthalmology. Eastern Europe". 2021:11(3);311-320. https://doi.org/10.34883/PI.2021.11.3.030
Агзамова С.С. Ретроспективный анализ состояния офтальмологического статуса при травмах скулоорбитального комплекса. Stomatologiya. 2021;1(82):89–92. https://doi.org/10.34920/2091-5845-2021-29
Туйчибаева ДМ, Янгиева НР. Усовершенствование консервативного лечения возрастной макулодистрофии. Практическая медицина. 2018;16(4): 81–83. [Tuychibaeva DM, Yangieva NR. Improvement of conservative treatment of age-related macular degeneration. Practical medicine. 2018;16(4): 81–83. (In Russia)].
Bakhritdinova F. A., Urmanova F. M., Tuychibaeva D.M. Diagnostic role of angiography optical coherent tomography in diabetic retinopathu. Advanced Opthalmology. 2023;2(2):29-34. DOI: https://doi.org/10.57231/j.ao.2023.2.2.005
Bakhritdinova F. A., Urmanova F. M., Tuychibaeva D.M. Evaluation of the effectiveness of a conservative method of treatment of early srage diabetic retinopathy. - Advanced Opthalmology. - 2023;2(2):35-41. DOI: https://doi.org/10.57231/j.ao.2023.2.2.006
Загрузки
Опубликован
Выпуск
Раздел
Лицензия
Copyright (c) 2024 Bilalov E. N., Ahmedova S. M., Nozimov A. E., Yuldashеv S. A.
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.